Showing results (371-380 of 570) with videos related to

Sort By:
Pageof 57
Journal of Clinical Microbiology|November 4, 2016
Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and CommunitiesLuis Furuya-Kanamori, Thomas V Riley, David L Paterson, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trialsMyra W Popejoy, David L Paterson, Daniel Cloutier, et al.
American Journal of Infection Control|July 24, 2019
Skin colonization at peripheral intravenous catheter insertion sites increases the risk of catheter colonization and infectionMd Abu Choudhury, Hanna E Sidjabat, Hosam M Zowawi, et al.
Surgical Infections|January 20, 2007
In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends)Grant V Bochicchio, Fernando Baquero, Po-Ren Hsueh, et al.
Open Forum Infectious Diseases|April 27, 2022
Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysisYukiko Ezure, Veronica Rico, David L Paterson, et al.
International Journal of Antimicrobial Agents|November 16, 2010
Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infectionsZubair A Qureshi, David L Paterson, Diana L Pakstis, et al.
Mbio|April 8, 2026
A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocolAkito Kawai, Christi L McElheny, Ryan K Shields, et al.
Diagnostic Microbiology and Infectious Disease|February 16, 2025
A real-world investigation into prescribing patterns and effectiveness of ceftolozane/tazobactam among critically ill patients from SPECTRAAlex Soriano, David L Paterson, Florian Thalhalmmer, et al.
Clinical Microbiology Reviews|May 15, 2020
Antimicrobial Resistance in ESKAPE PathogensDavid M P De Oliveira, Brian M Forde, Timothy J Kidd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Epidemiological profile of linezolid-resistant coagulase-negative staphylococciBrian A Potoski, Jennifer Adams, Lloyd Clarke, et al.
Pageof 57